• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22345 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2004     Washington State Department of Labor and Industries (WSDLI) Percutaneous discectomy for disc herniation
1996     Wessex Institute for Health Research and Development (WIHRD) Ceredase in the treatment of type 1 Gaucher's disease
1996     Wessex Institute for Health Research and Development (WIHRD) Cognitive behavioural therapy in the treatment of chronic fatigue syndrome
1996     Wessex Institute for Health Research and Development (WIHRD) Pallidotomy for Parkinson's disease
1996     Wessex Institute for Health Research and Development (WIHRD) Alpha interferon in the treatment of chronic myeloid leukaemia
1996     Wessex Institute for Health Research and Development (WIHRD) Prestorage filtration of blood components for patients who are chronically transfusion dependent
1996     Wessex Institute for Health Research and Development (WIHRD) Goserelin or other gonadotrophin releasing hormone (GnRH) analogues in the treatment of advanced prostate cancer
1996     Wessex Institute for Health Research and Development (WIHRD) Implantable infusion devices (IIPs) for long-term pain management
1996     Wessex Institute for Health Research and Development (WIHRD) Paclitaxel as a first line chemotherapy agent in the treatment of ovarian cancer
1996     Wessex Institute for Health Research and Development (WIHRD) Growth hormone in children (for growth hormone deficiency, Turner's syndrome, chronic renal failure and idiopathic short stature)
1996     Wessex Institute for Health Research and Development (WIHRD) Factor V Leiden screening in oral contraceptive users
1996     Wessex Institute for Health Research and Development (WIHRD) 5-fluorouracil (5-FU) as adjuvant chemotherapy in Duke's stage C colorectal cancer
1996     Wessex Institute for Health Research and Development (WIHRD) Extracorporeal membrane oxygenation for term neonates with severe respiratory failure
1996     Wessex Institute for Health Research and Development (WIHRD) Screening for hepatitis B in pregnancy
1996     Wessex Institute for Health Research and Development (WIHRD) Laser trabeculoplasty as primary therapy for glaucoma
1996     Wessex Institute for Health Research and Development (WIHRD) Copolymer 1 in relapsing-remitting multiple sclerosis
1996     Wessex Institute for Health Research and Development (WIHRD) Zafirlukast (Accolate) in asthma
1996     Wessex Institute for Health Research and Development (WIHRD) Evening primrose oil for cyclical mastalgia
1997     Wessex Institute for Health Research and Development (WIHRD) Auditory integration training in autism
1997     Wessex Institute for Health Research and Development (WIHRD) The therapeutic community method of treatment for borderline personality disorder
1997     Wessex Institute for Health Research and Development (WIHRD) Gastroplasty for severe obesity
1997     Wessex Institute for Health Research and Development (WIHRD) Donepezil in the treatment of mild to moderate senile dementia of the Alzheimer type (SDAT)
1997     Wessex Institute for Health Research and Development (WIHRD) In-patient vs out-patient pain management programmes that adopt a cognitive behavioural approach
1997     Wessex Institute for Health Research and Development (WIHRD) On-demand recombinant factor VIII for people with haemophilia A
1997     Wessex Institute for Health Research and Development (WIHRD) HMG CO-A reductase inhibitor treatment in the prevention of coronary heart disease
2001     Wessex Institute for Health Research and Development (WIHRD) Microdiscectomy for prolapsed intervertebral disc
1997     Wessex Institute for Health Research and Development (WIHRD) Riluzole for motor neurone disease
2001     Wessex Institute for Health Research and Development (WIHRD) Cryotherapy for prostatic cancer
1997     Wessex Institute for Health Research and Development (WIHRD) Tacrolimus after kidney transplantation
2001     Wessex Institute for Health Research and Development (WIHRD) Spinal cord stimulation for chronic pain
1997     Wessex Institute for Health Research and Development (WIHRD) Growth hormone for growth hormone deficient adults
2001     Wessex Institute for Health Research and Development (WIHRD) Osteo-odonto-keratoprosthesis as a treatment for severe corneal opacities
1997     Wessex Institute for Health Research and Development (WIHRD) Screening staff for methicillin resistant Staphylococcus aureus (MRSA)
2001     Wessex Institute for Health Research and Development (WIHRD) Thermal laser photocoagulation for age related macular degeneration
1997     Wessex Institute for Health Research and Development (WIHRD) Interferon beta-1a in relapsing-remitting multiple sclerosis
2001     Wessex Institute for Health Research and Development (WIHRD) Hip resurfacing in younger people with osteoarthritis
1998     Wessex Institute for Health Research and Development (WIHRD) Methylphenidate in children with hyperactivity
2001     Wessex Institute for Health Research and Development (WIHRD) Effects of desensitisation treatments and clinical ecology for multiple chemical sensitivity and related disorders
1998     Wessex Institute for Health Research and Development (WIHRD) Bisphosphonates (alendronate and etidronate) in the management of osteoporosis
2001     Wessex Institute for Health Research and Development (WIHRD) Photodynamic phototherapy (including verteporfin) for neovascular age related macular degeneration
1998     Wessex Institute for Health Research and Development (WIHRD) Lamotrigine as monotherapy for epilepsy in adults
2001     Wessex Institute for Health Research and Development (WIHRD) Laparoscopic ablation or resection of endometriosis deposits for moderate and severe endometriosis
1998     Wessex Institute for Health Research and Development (WIHRD) Screening for hepatitis C in intravenous drug users and genito-urinary clinic attendees
2001     Wessex Institute for Health Research and Development (WIHRD) Repeat inpatient rehabilitation for people with relapsed alcohol addiction
1998     Wessex Institute for Health Research and Development (WIHRD) Vagus nerve stimulation in epilepsy
2001     Wessex Institute for Health Research and Development (WIHRD) Stereotactic radiosurgery for brain tumours and arteriovenous malformations
1998     Wessex Institute for Health Research and Development (WIHRD) Tinnitus retraining therapy
2001     Wessex Institute for Health Research and Development (WIHRD) Pre- and peri-operative antibiotic prophylaxis for colorectal surgery
1998     Wessex Institute for Health Research and Development (WIHRD) The use of olanzapine as a first and second choice treatment in schizophrenia
2001     Wessex Institute for Health Research and Development (WIHRD) Pre-implantation diagnosis
2001     Wessex Institute for Health Research and Development (WIHRD) Functional electrical stimulation for limb motor dysfunction following stroke
2001     Wessex Institute for Health Research and Development (WIHRD) Brachytherapy for localised prostate cancer
2001     Wessex Institute for Health Research and Development (WIHRD) Surgical interventions for morbid obesity
2001     Wessex Institute for Health Research and Development (WIHRD) Effects of TNF-alpha antagonists in people with rheumatoid arthritis
2001     Wessex Institute for Health Research and Development (WIHRD) Ambulatory versus conventional blood pressure monitoring
2002     Wessex Institute for Health Research and Development (WIHRD) Growth hormone replacement therapy for adults with growth hormone deficiency
2002     Wessex Institute for Health Research and Development (WIHRD) Immunotherapy for seasonal rhinitis, asthma and bee sting venom allergy
2002     Wessex Institute for Health Research and Development (WIHRD) Cox-II inhibitors versus non-steroidal anti-inflammatory drugs in rheumatoid and osteoarthritis patients: gastrointestinal effects
2002     Wessex Institute for Health Research and Development (WIHRD) Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-Alzheimer's dementia
2002     Wessex Institute for Health Research and Development (WIHRD) Pre-operative delay after femoral fracture
2002     Wessex Institute for Health Research and Development (WIHRD) Insulin pumps, conventional and intensive multiple injection insulin therapy for type 1 diabetes mellitus
2002     Wessex Institute for Health Research and Development (WIHRD) Outpatient physiotherapy services for low back pain
2002     Wessex Institute for Health Research and Development (WIHRD) Update report: Non-myeloablative bone marrow and peripheral blood stem cell transplant
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for multiple sclerosis
2002     Wessex Institute for Health Research and Development (WIHRD) Lung volume reduction surgery for diffuse emphysema
2002     Wessex Institute for Health Research and Development (WIHRD) Selective denervation for spasmodic torticollis
2002     Wessex Institute for Health Research and Development (WIHRD) Imatinib for gastrointestinal stromal tumours
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for carbon monoxide poisoning
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy in people with necrotising fasciitis or Fournier's gangrene
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for central retinal artery occlusion
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for central osteoradionecrosis
2002     Wessex Institute for Health Research and Development (WIHRD) Immediate versus delayed breast reconstruction
1999     Wessex Institute for Health Research and Development (WIHRD) Reducing the interval for diabetic retinal screening
2003     Wessex Institute for Health Research and Development (WIHRD) Cosmetic breast augmentation
2000     Wessex Institute for Health Research and Development (WIHRD) Dalteparin and enoxaparin for unstable angina and non-Q-wave myocardial infarction: update
2003     Wessex Institute for Health Research and Development (WIHRD) Outcomes of abdominoplasty
2003     Wessex Institute for Health Research and Development (WIHRD) Arthroscopic lavage for knee osteoarthritis
2003     Wessex Institute for Health Research and Development (WIHRD) Sympathectomy for facial blushing
2003     Wessex Institute for Health Research and Development (WIHRD) Coil embolisation of ruptured or unruptured intracranial aneurysms
2003     Wessex Institute for Health Research and Development (WIHRD) Cardiac resynchronisation for heart failure
2003     Wessex Institute for Health Research and Development (WIHRD) Successive attempts at in vitro fertilization
2003     Wessex Institute for Health Research and Development (WIHRD) Update report: Effects of desensitisation treatments and clinical ecology for multiple chemical sensitivity and related disorders
2003     Wessex Institute for Health Research and Development (WIHRD) Uterine artery embolisation for fibroids
2003     Wessex Institute for Health Research and Development (WIHRD) Cochlear implants in adults
2003     Wessex Institute for Health Research and Development (WIHRD) Bernese periacetabular osteotomy for developmental dysplasia of the hip
2003     Wessex Institute for Health Research and Development (WIHRD) Hypnotherapy for anxiety disorders
2003     Wessex Institute for Health Research and Development (WIHRD) Laser treatment of unwanted hair
2003     Wessex Institute for Health Research and Development (WIHRD) Alemtuzumab for chronic lymphocytic leukaemias
2003     Wessex Institute for Health Research and Development (WIHRD) Oesophago-oesophageal anastomosis for oesophageal atresia or stenosis in children
2003     Wessex Institute for Health Research and Development (WIHRD) Oesophago-gastric anastomosis and interposition surgery for oesophageal atresia or stenosis in children
2003     Wessex Institute for Health Research and Development (WIHRD) Music therapy for children with autistic spectrum disorder
2003     Wessex Institute for Health Research and Development (WIHRD) Spinal manipulation for chronic low back pain
1999     Wessex Institute for Health Research and Development (WIHRD) The use of interferon alfa in the treatment of metastatic cutaneous melanoma
1999     Wessex Institute for Health Research and Development (WIHRD) Combination therapy (ribavirin and interferon alfa) to replace interferon alfa alone for the treatment of patients with moderate hepatitis C
1998     Wessex Institute for Health Research and Development (WIHRD) Irinotecan as second line chemotherapy in colorectal cancer (preliminary report)
1998     Wessex Institute for Health Research and Development (WIHRD) Psycho-social interventions in oncology: counselling services for women with breast cancer
1998     Wessex Institute for Health Research and Development (WIHRD) Stents for coronary artery disease (CAD)
1998     Wessex Institute for Health Research and Development (WIHRD) Surgical gender reassignment for male to female transsexual people
2003     Wessex Institute for Health Research and Development (WIHRD) Sensory or auditory integration therapy for children with autistic spectrum disorders
2003     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen for osteomyelitis